The market for medical software is booming, but behind this growth lie growing risks. In the race for hypergrowth, both startups and large companies are increasingly launching products before fully validating their safety and effectiveness. This approach allows them to grab a market share quickly, but on the flip side, it can pose threats to patient safety and lead to serious regulatory issues.
Read More
